查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060262

血液傳染病檢查市場分析及預測（至2035年）：類型、產品類型、服務、技術、應用、設備、流程、最終用戶、解決方案

Bloodstream Infection Testing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Device, Process, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球血液傳染病檢查市場預計將從2025年的42億美元成長到2035年的78億美元，年複合成長率（CAGR）為6.2%。血液傳染病檢查市場結構較為一體化，分子診斷及微生物檢測兩大細分市場分別約佔市場佔有率的45%及30%。主要產品類型包括儀器、試劑和軟體解決方案，應用領域主要為醫院、診斷檢查室和研究機構。市場規模的成長主要受每年診斷檢測數量增加的推動，反映出對快速且準確感染疾病檢測日益成長的需求。

細菌傳染病檢查是目前最主要的應用領域，這反映了細菌性血流感染疾病的高發生率以及及時診斷的迫切需求。真菌和病毒傳染病檢查也佔據重要地位，這得益於公眾意識的提高和發病率的上升。醫院和診所是主要用戶，他們致力於降低敗血症的發生率並改善治療效果。個人化醫療的發展趨勢推動更具針對性和更有效率的診斷測試的研發。

市場區隔
種類 常規檢測、快速檢測、其他
產品 儀器、試劑/試劑盒、軟體、其他
服務 檢驗服務、諮詢服務、其他
技術 PCR、微陣列、免疫檢測、質譜分析、次世代定序、其他
用途 敗血症、菌血症、真菌感染、其他
裝置 全自動系統、半自動系統、手動系統、其他
過程 檢體採集、樣品製備、檢測及其他過程。
最終用戶 醫院、診斷檢查室、學術和研究機構以及其他機構
解決方案 內部解決方案、外包解決方案、其他

在終端用戶領域，醫院和診斷檢查室是血液傳染病檢查解決方案的主要用戶，這主要是由於需要準確快速的診斷來有效管理患者照護。院內感染發生率的上升是該領域的主要促進因素。居家醫療領域興起，以滿足日益成長的居家醫療服務需求，而遠端監測和檢測等技術的進步為此提供了支援。

區域概覽

北美憑藉其高度發展的醫療基礎設施以及對感染控制和患者安全的高度重視，在血液傳染病檢查市場佔據主導地位。該地區受益於分子檢測和自動化血液培養系統等先進診斷技術的早期應用，能夠快速準確地檢測感染疾病。高昂的醫療費用支出、優惠的償付政策以及主要廠商的強大市場地位進一步推動了這些技術的普及。此外，醫院感染和敗血症病例的不斷增加也推動了對高效檢測解決方案的需求，鞏固了該地區在全球市場的主導地位。

亞太地區是血液傳染病檢查市場成長最快的地區，這主要得益於醫療基礎設施的不斷改善和感染疾病負擔的日益加重。診斷檢查室投資的增加、人們對疾病早期檢測意識的提高以及醫療服務可近性的改善，都在加速先進檢測解決方案的普及應用。該地區龐大的患者群體和檢測系統的持續現代化也為其發展提供了助力。此外，各國政府為加強感染控制和擴大篩檢計畫所採取的措施也促進了市場成長，使亞太地區成為血液感染疾病診斷領域重要的新興中心。

主要趨勢和促進因素

敗血症和醫院感染發生率增加：

全球醫療系統中敗血症、菌血症和院內感染發生率的不斷上升是推動血液傳染病檢查市場成長的主要因素。侵入性操作的增加、人口老化以及慢性病盛行率的上升顯著增加了血液感染疾病的風險。此外，日益嚴重的抗生素抗藥性使得快速且準確的病原體檢測對於制定有效的治療策略非常重要。醫療機構正擴大採用先進的診斷工具，例如基於PCR的檢測和自動化血液培養系統，以提高早期檢出率、降低死亡率並改善患者預後，加速市場成長。

擴大快速分子診斷和即時檢測：

關鍵的市場機會在於快速分子診斷和即時檢測（POC）解決方案的日益普及。聚合酶鍊式反應（PCR）、次世代定序和自動化識別系統等技術創新顯著縮短了感染疾病檢測所需時間，加快了臨床決策。急診和加護病房（ICU）對分散式檢查的需求不斷成長，進一步推動了這些技術的應用。此外，領先企業不斷取得技術進步並產品推出，也擴大了更精準、更有效率的檢測平台的覆蓋範圍。這些趨勢為市場擴張創造了巨大的機會，尤其是在重症監護和醫療負擔沉重的醫療機構中。

目錄

第1章 執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 常規測試
    • 快速檢測
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 試劑和試劑盒
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 檢查服務
    • 諮詢服務
    • 其他
  • 市場規模及預測：依技術分類
    • PCR
    • 微陣列
    • 免疫檢測
    • 質譜分析
    • 次世代定序
    • 其他
  • 市場規模及預測：依應用領域分類
    • 敗血症
    • 菌血症
    • 真菌血症
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診斷檢測實驗室
    • 學術和研究機構
    • 其他
  • 市場規模及預測：依製程分類
    • 檢體採集
    • 樣品製備
    • 偵測
    • 其他
  • 市場規模及預測：依設備分類
    • 自動化系統
    • 半自動系統
    • 手動系統
    • 其他
  • 市場規模及預測：依解決方案分類
    • 內部解決方案
    • 外包解決方案
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章 公司簡介

  • Roche Diagnostics
  • bioMerieux
  • Becton Dickinson
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Siemens Healthineers
  • Danaher Corporation
  • Qiagen
  • Hologic
  • Luminex Corporation
  • Bio-Rad Laboratories
  • Cepheid
  • Grifols
  • Meridian Bioscience
  • GenMark Diagnostics
  • T2 Biosystems
  • Accelerate Diagnostics
  • F. Hoffmann-La Roche
  • Bruker Corporation
  • Illumina

第9章 關於我們

簡介目錄
Product Code: GIS27001

The global Bloodstream Infection Testing Market is projected to grow from $4.2 billion in 2025 to $7.8 billion by 2035, at a compound annual growth rate (CAGR) of 6.2%. The Bloodstream Infection Testing Market is characterized by its moderately consolidated structure, with the leading segments being molecular diagnostics and microbiology testing, holding approximately 45% and 30% of the market share, respectively. Key product categories include instruments, reagents, and software solutions, with applications primarily in hospitals, diagnostic laboratories, and research institutes. The market volume is driven by the increasing number of diagnostic tests conducted annually, reflecting a growing demand for rapid and accurate infection detection.

The Application segment is dominated by bacterial infection testing, reflecting the high prevalence of bacterial bloodstream infections and the critical need for timely diagnosis. Fungal and viral infection testing are also significant, with increasing awareness and incidence rates driving demand. Hospitals and clinics are the primary users, focusing on reducing the incidence of sepsis and improving treatment outcomes. The trend towards personalized medicine is influencing the development of more targeted and efficient diagnostic tests.

Market Segmentation
TypeConventional Testing, Rapid Testing, Others
ProductInstruments, Reagents & Kits, Software, Others
ServicesLaboratory Services, Consulting Services, Others
TechnologyPCR, Microarray, Immunoassay, Mass Spectrometry, Next-Generation Sequencing, Others
ApplicationSepsis, Bacteremia, Fungemia, Others
DeviceAutomated Systems, Semi-Automated Systems, Manual Systems, Others
ProcessSample Collection, Sample Preparation, Detection, Others
End UserHospitals, Diagnostic Laboratories, Academic & Research Institutes, Others
SolutionsIn-House Solutions, Outsourced Solutions, Others

In the End User segment, hospitals and diagnostic laboratories are the primary consumers of bloodstream infection testing solutions, driven by the need for accurate and rapid diagnosis to manage patient care effectively. The rising incidence of hospital-acquired infections is a key driver for this segment. The home healthcare segment is emerging, supported by technological advancements that enable remote monitoring and testing, catering to the growing demand for at-home medical services.

Geographical Overview

North America dominates the bloodstream infection testing market due to its highly advanced healthcare infrastructure and strong focus on infection control and patient safety. The region benefits from early adoption of advanced diagnostic technologies such as molecular testing and automated blood culture systems, enabling rapid and accurate detection of infections. High healthcare spending, favorable reimbursement policies, and strong presence of leading diagnostic companies further support widespread adoption. In addition, increasing cases of hospital-acquired infections and sepsis have led to greater demand for efficient testing solutions, reinforcing the region's leadership in the global market.

Asia Pacific is the fastest-growing region in the bloodstream infection testing market, driven by expanding healthcare infrastructure and rising burden of infectious diseases. Increasing investments in diagnostic laboratories, growing awareness about early disease detection, and improving access to healthcare services are accelerating adoption of advanced testing solutions. The region also benefits from large patient populations and ongoing modernization of laboratory systems. Additionally, government initiatives focused on strengthening infection control and increasing screening programs are supporting market growth, positioning Asia Pacific as a key expansion hub for bloodstream infection diagnostics.

Key Trends and Drivers

Rising Incidence of Sepsis and Hospital-Acquired Infections:

The bloodstream infection testing market is primarily driven by the increasing incidence of sepsis, bacteremia, and hospital-acquired infections across global healthcare systems. Rising use of invasive procedures, aging populations, and higher prevalence of chronic diseases have significantly increased vulnerability to bloodstream infections. Additionally, growing antimicrobial resistance is making rapid and accurate pathogen detection essential for effective treatment decisions. Healthcare providers are increasingly adopting advanced diagnostic tools such as PCR-based assays and automated blood culture systems to improve early detection, reduce mortality rates, and enhance patient outcomes, thereby accelerating market growth.

Expansion of Rapid Molecular Diagnostics and Point-of-Care Testing:

A major opportunity in the market lies in the growing adoption of rapid molecular diagnostics and point-of-care (POC) testing solutions. Innovations such as PCR, next-generation sequencing, and automated identification systems are significantly reducing turnaround time for infection detection, enabling faster clinical decision-making. Increasing demand for decentralized testing in emergency departments and intensive care units is further supporting adoption. In addition, technological advancements and ongoing product launches by key players are expanding the availability of more accurate and efficient testing platforms. These developments are creating strong opportunities for market expansion, especially in critical care and high-burden healthcare settings.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Process
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Conventional Testing
    • 4.1.2 Rapid Testing
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents & Kits
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Laboratory Services
    • 4.3.2 Consulting Services
    • 4.3.3 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 PCR
    • 4.4.2 Microarray
    • 4.4.3 Immunoassay
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Next-Generation Sequencing
    • 4.4.6 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Sepsis
    • 4.5.2 Bacteremia
    • 4.5.3 Fungemia
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Academic & Research Institutes
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Process (2020-2035)
    • 4.7.1 Sample Collection
    • 4.7.2 Sample Preparation
    • 4.7.3 Detection
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 Automated Systems
    • 4.8.2 Semi-Automated Systems
    • 4.8.3 Manual Systems
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 In-House Solutions
    • 4.9.2 Outsourced Solutions
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Process
      • 5.2.1.8 Device
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Process
      • 5.2.2.8 Device
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Process
      • 5.2.3.8 Device
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Process
      • 5.3.1.8 Device
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Process
      • 5.3.2.8 Device
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Process
      • 5.3.3.8 Device
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Process
      • 5.4.1.8 Device
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Process
      • 5.4.2.8 Device
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Process
      • 5.4.3.8 Device
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Process
      • 5.4.4.8 Device
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Process
      • 5.4.5.8 Device
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Process
      • 5.4.6.8 Device
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Process
      • 5.4.7.8 Device
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Process
      • 5.5.1.8 Device
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Process
      • 5.5.2.8 Device
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Process
      • 5.5.3.8 Device
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Process
      • 5.5.4.8 Device
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Process
      • 5.5.5.8 Device
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Process
      • 5.5.6.8 Device
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Process
      • 5.6.1.8 Device
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Process
      • 5.6.2.8 Device
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Process
      • 5.6.3.8 Device
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Process
      • 5.6.4.8 Device
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Process
      • 5.6.5.8 Device
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Roche Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 bioMerieux
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Becton Dickinson
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Thermo Fisher Scientific
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Abbott Laboratories
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Siemens Healthineers
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Danaher Corporation
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Qiagen
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Hologic
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Luminex Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Bio-Rad Laboratories
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Cepheid
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Grifols
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Meridian Bioscience
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 GenMark Diagnostics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 T2 Biosystems
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Accelerate Diagnostics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 F. Hoffmann-La Roche
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Bruker Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Illumina
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us